学術論文

英文

• Isohashi F, Yoshida K, Murakami N, Masui K, Ishihara S, Ohkubo Y, Kaneyasu Y, Kinoshita R, Kotsuma T, Takaoka Y, Tanaka E, Nagao A, Ogawa K, Yamazaki H : Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes. Radiother Oncol. 2024 Apr 5;195:110269. doi: 10.1016/j.radonc.2024.110269. Online ahead of print. PMID: 38583719
• Saito Y, Suzuki R, Miyamoto N, Sutherland KL, Kanehira T, Tamura M, Mori T, Nishioka K, Hashimoto T, Aoyama H. A new predictive parameter for dose-volume metrics in intensity-modulated radiation therapy planning for prostate cancer: Initial phantom study. J Appl Clin Med Phys (IF: 1.679; Q1). 2024 Apr;25(4):e14250. doi: 10.1002/acm2.14250. Epub 2023 Dec 25. PMID: 38146130
• Nakazono A, Motegi H, Suzuki M, Nakamaru Y, Yamaguchi S, Ishi Y, Kano S, Tsushima N, Honma A, Suzuki T, Kimura S, Hamada S, Taguchi J, Shimizu Y, Mori T, Yasuda K, Aoyama H, Kinoshita I, Fujimura M, Homma A. Clinical outcomes for olfactory neuroblastoma. Front Oncol (IF: 4.848; Q1). 2024 May 2;14:1329572.      doi: 10.3389/fonc.2024.1329572. eCollection 2024. PMID: 38756668
• Yoshimura T, Yamada R, Kinoshita R, Matsuura T, Kanehira T, Tamura H, Nishioka K, Yasuda K, Taguchi H, Katoh N, Kobashi K, Hashimoto T, Aoyama H. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization. J Radiat Res (IF: 1.95; Q1). 2024 May 23;65(3):369-378. doi: 10.1093/jrr/rrae008. PMID: 38499489
• Oki S, Ishi Y, Sawaya R, Okamoto M, Motegi H, Tanei ZI, Tsuda M, Mori T, Nishioka K, Kanno-Okada H, Aoyama H, Tanaka S, Yamaguchi S, Fujimura M. Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults. Acta Neurochir (Wien) (IF: 1.817; Q1). 2024 Jun 12;166(1):263.    doi: 10.1007/s00701-024-06154-3. PMID: 38864949

• Lau B, Wu YF, Cui S, Fu J, Jackson S, Pham D, Dubrowski P, Eswarappa S, Skinner L, Shirato H, Taguchi H, Gensheimer MF, Gee H, Chin AL, Diehn M, Loo BW Jr, Moiseenko V, Vitzthum LK. Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial. Radiother Oncol (IF: 4.856; Q1). 2024 Jul;196:110317.  doi:10.1016/j.radonc.2024.110317. Epub 2024 Apr 27. PMID: 38679202
• Saito T, Shikama N, Takahashi T, Nakamura N, Mori T, Nakajima K, Koizumi M, Sekii S, Ebara T, Kiyohara H, Higuchi K, Yorozu A, Nishimura T, Ejima Y, Harada H, Araki N, Miwa M, Yamada K, Kawamoto T, Imano N, Heianna J, Nozaki M, Wada Y, Ohkubo Y, Uchida N, Watanabe M, Kosugi T, Miyazawa K, Yasuda S, Onishi H. Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey†. J Radiat Res (IF: 1.95; Q1). 2024 Jul 22;65(4):532-539. doi:10.1093/jrr/rrae048. PMID: 38923425
• Miyamoto N, Katoh N, Kanehira T, Yokokawa K, Suzuki R, Uchinami Y, Taguchi H, Abo D, Aoyama H. Clinical application of real-time tumor-tracking for stereotactic volumetric modulated arc therapy for liver tumors. Phys Imaging Radiat Oncol (IF: 2.19; Q2). 2024 Aug 5;31:100623. doi: 10.1016/j.phro.2024.100623.                               eCollection 2024 Jul. PMID: 39224689
• Yoshimura T, Kondo K, Hashimoto T, Nishioka K, Mori T, Kanehira T, Matsuura T, Takao S, Tamura H, Matsumoto T, Sutherland K, Aoyama H. Geometric target margin strategy of proton craniospinal irradiation for pediatric medulloblastoma. J Radiat Res (IF: 1.95; Q1). 2024 Sep 24;65(5):676-688. doi: 10.1093/jrr/rrae066.  PMID: 39278649

• Numakura K, Takao S, Matsuura T, Yokokawa K, Chen Y, Uchinami Y, Taguchi H, Katoh N, Aoyama H, Tomioka S, Miyamoto N. Application of motion prediction based on a long short-term memory network for imaging dose reduction in real-time tumor-tracking radiation therapy. Phys Med (IF: 2.485; Q1). 2024 Sep;125:104507. doi: 10.1016/j.ejmp.2024.104507. Epub 2024 Aug 31. PMID: 39217787
• Harada H, Shikama N, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Saito T, Asakawa I, Takahashi T, Shigematsu N. Multi-institutional prospective observational study of radiotherapy for metastatic bone tumor. J Radiat Res (IF: 1.95; Q1). 2024 Sep 24;65(5):701-711. doi: 10.1093/jrr/rrae060.  PMID: 39162649
• Uchinami Y, Dasgupta A, Nishioka K, Handoko, Goda JS, Kim JW, Zaid RM, Kai Yun O, Mehmood H, Chitapanarux I, Chopra S, Aoyama H. Patterns of Care for Brain Metastases in Asia: A Real-World Survey Conducted by the Federation of Asian Organizations for Radiation Oncology. JCO Glob Oncol (Report missing IFs). 2024 Oct;10:e2400222. doi: 10.1200/GO.24.00222. Epub 2024 Oct 17. PMID: 39418623
• Yoshimura T, Morii Y, Tamori H, Kita R, Hashimoto T, Aoyama H, Ogasawara K. Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan. J Radiat Res (IF: 1.95; Q1). 2024 Nov 19:rrae086. doi: 10.1093/jrr/rrae086. Online ahead of print. PMID: 39562156
• Fujii Y, Ueda H, Takayanagi T, Nishioka K, Mori T, Hashimoto T, Aoyama H, Umegaki K, Matsuura T. A simulation study of MR-guided proton therapy system using iron-yoked superconducting open MRI: a conceptual study. J Radiat Res (IF: 1.95; Q1). 2024 Dec 3;65(6):824-835. doi: 10.1093/jrr/rrae075. PMID: 39365681
• Kikkawa Y, Ueda H, Uchinami Y, Katoh N, Aoyama H, Ito YM, Yokokawa K, Chen Y, Matsuura T, Miyamoto N, Takao S. Investigation of interfractional range variation owing to anatomical changes with beam directions based on water equivalent thickness in proton therapy for pancreatic cancer. J Radiat Res (IF: 1.95; Q1). 2024 Dec 3;65(6):813-823. doi: 10.1093/jrr/rrae069. PMID: 39376078
• Koizumi F, Katoh N, Kanehira T, Kawamoto Y, Nakamura T, Kakisaka T, Myojin M, Nishiyama N, Yonesaka A, Otsuka M, Takashina R, Minatogawa H, Higaki H, Uchinami Y, Taguchi H, Nishioka K, Yasuda K, Miyamoto N, Yokota I, Kobashi K, Aoyama H. Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy. Phys Imaging Radiat Oncol (IF: 2.19; Q2).                                2024 Dec 22;33:100690. doi: 10.1016/j.phro.2024.100690. eCollection 2025 Jan.      PMID: 39817285

• Sanuki N, Kimura T, Takeda A, Ariyoshi K, Oyamada S, Yamaguchi T, Tsurugai Y, Doi Y, Kokubo M, Imagumbai T, Katoh N, Eriguchi T, Ishikura S. Final Results of a Multicenter Prospective Study of Stereotactic Body Radiation Therapy for Previously Untreated Solitary Primary Hepatocellular Carcinoma (The STRSPH Study). Int J Radiat Oncol Biol Phys (IF: 5.859; Q1). 2024 Dec 18:S0360-3016(24)03562-4. doi: 10.1016/j.ijrobp.2024.10.040. Online ahead of print.        PMID: 39706374
• Yasuda K, Kiyota N, Matsuura K, Saito S, Honma Y, Imamura Y, Tanaka K, Zenda S, Onoe T, Kodaira T, Kobayashi S, Aoyama H, Hanai N, Homma A. Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group. Front Oncol (IF: 4.848; Q1). 2025 Jan 8;14:1441056. doi: 10.3389/fonc.2024.1441056. eCollection 2024. PMID: 39845314
• Gandhi AK, Chopra S, Rastogi M, Mallick I, Cruz MC, Yasuda K, Sum YY, Nagata Y, Wu HG, Prajogi GB, Kodrat H, Ma M, Nisar A, Chitapanarux I. Multicentric Cross-Sectional Survey to Assess the Variation of Fractionation Strategies Used in the Management of Head and Neck Cancers in the Asian Region (INNOCENCE-ASIA). JCO Glob Oncol (Report missing IFs). 2025 Jan;11:e2400349. doi: 10.1200/GO-24-00349. Epub 2025 Jan 16. PMID: 39819125
• Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N. Health Utility of Pain Response Versus Nonresponse to Palliative Radiation Therapy for Symptomatic Bone Metastases: Analyses Based on Real-World Data from 26 Centers. J Palliat Med (IF: 2.085; Q1). 2025 Jan;28(1):42-49. doi: 10.1089/jpm.2024.0208. Epub 2024 Dec 27. PMID: 39729365
• Sato M, Osawa T, Nishioka K, Miyazaki T, Takahashi S, Mori T, Hashimoto T, Miyata H, Matsumoto R, Abe T, Ohashi K, Murai S, Ito YM, Shinohara N. Decision regret after curative treatment and its association with the decision-making process and quality of life for prostate cancer patients. Int J Urol (IF: 2.445; Q2). 2025 Jan;32(1):95-102. doi: 10.1111/iju.15602. Epub 2024 Oct 9. PMID: 39382251

• Nishioka K, Ishimoto T, Sato M, Yasuda R, Nakamura Y, Watanabe H, Suzuki T, Araragi Y, Kato Y, Yoshida KI, Murayama N. Optimizing oral 3-hydroxybutyrate dosage using pharmacokinetic model to improve cognitive function and mood in healthy subjects. Front Nutr (IF: 3.365; Q1). 2025 Jan 8;11:1470331. doi: 10.3389/fnut.2024.1470331. eCollection 2024. PMID: 39867559
• Utsumi N, Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Ueno S, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N. Quality of life improvement after radiotherapy for bone metastases assessed using real-world data: a secondary analysis of a Nationwide Multicenter Cohort Study. Jpn J Clin Oncol (IF: 1.914; Q2). 2025 Feb 4;55(2):140-147. doi: 10.1093/jjco/hyae150. PMID: 39479804